Comparative Efficacy of Duochrome Test Verse +1 Blur Test in Detecting Refracting Error Across Different Ages
1 other identifier
interventional
33
1 country
1
Brief Summary
The comparative efficacy of the duochrome test versus +1 blur test in detecting refractive errors across different ages remains under-explored in current ophthalmic research. While the duochrome test is widely used to refine prescriptions, its standalone effectiveness compared to +1 blur test based refraction has not been thoroughly investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 23, 2025
CompletedFirst Posted
Study publicly available on registry
June 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedJuly 16, 2025
July 1, 2025
5 months
May 23, 2025
July 12, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Visual Function Index (VF-14) Questionnaire:
Scores on all activities that the person performed or did not perform because of vision were then averaged, yielding a value from 0 to 4. This value was multiplied by 25, giving a final score from 0 to 100. A score of 100 indicates able to do all applicable activities score of 0 indicates unable to do all applicable activities because of vision
12 Months
+1 blur test
Adding a +1.00 diopter (DS) lens to a patient's final refraction and measuring their distance visual acuity (VA). There are 4 questions with 5 different options ranging from 0-4. minimum score is 0 and maximum score is 16 with spherical correction.
12 Months
Duochrome Test
A duochrome test chart .There are 4 questions with 5 different options ranging from 0-4. minimum score is 0 and maximum score is 16 with spherical correction.
12 Months
Study Arms (2)
duochrome test and +1 blur test (Group1) 18-35
EXPERIMENTALduochrome test and +1 blur test (Group1) 36-60
ACTIVE COMPARATORInterventions
The participant is seated at a standard testing distance (typically 6 meters or 20 feet). A duochrome chart with black letters on a split red-green background is presented. After determining the subjective refraction, a +1.00 diopter (DS) lens is added to the final prescription. The participant is asked to read the distance visual acuity (VA) chart. The expectation is that the visual acuity should drop to 4 lines on Snellen chart (6/24) when the +1.00 DS lens is added. If VA reduces to 6/24: Indicates that the refraction is not over-minused or over-plussed (proper end point of refraction). If VA remains better than 6/24: Suggests the patient was still accommodating, possibly leading to over-minus (in myopes) or under-plus (in hyperopes) and the refraction should be re-evaluated.
Eligibility Criteria
You may qualify if:
- Age between 18 to 60 years old.
- Both genders.
- Those who have refractive error.
- Patients with no history of prior eye surgery.
- No active eye diseases affecting visual acuity, such as cataracts or retinal disorders.
- Ability to cooperate with both the duochrome test and +1 blur test.
You may not qualify if:
- Patients with severe visual impairment or neurological conditions affecting vision.
- Patients with nystagmus or conditions that could interfere with reliable testing.
- Age below 18 year and above 60 year excluded
- Those patients who don't show their consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eye professionals clinic (14-S DHA Phase 2 Ghazi road)
Lahore, Punjab Province, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 23, 2025
First Posted
June 3, 2025
Study Start
March 1, 2025
Primary Completion
August 1, 2025
Study Completion
February 28, 2026
Last Updated
July 16, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share